Behavioural abnormalities contribute to functional decline in Huntington's disease.
about
Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of NeurologyTherapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderMusic therapy in Huntington's disease: a protocol for a multi-center randomized controlled trial.Risk-taking and pathological gambling behavior in Huntington's diseaseNeural bases of dysphoria in early Huntington's disease.Irritability in pre-clinical Huntington's diseaseCognitive deficits in Huntington's disease on the Repeatable Battery for the Assessment of Neuropsychological Status.Neuropsychiatric Burden in Huntington's Disease."Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness.A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington's diseaseCognitive and functional decline in Huntington's disease: dementia criteria revisited.Challenges assessing clinical endpoints in early Huntington disease.Onset of Huntington's disease: can it be purely cognitive?Everyday cognition in prodromal Huntington diseaseDysthymia and apathy: diagnosis and treatment.Effect of tetrabenazine on motor function in patients with huntington disease.Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease.Neurocognitive correlates of apathy and anxiety in Parkinson's disease.The utilisation of operant delayed matching and non-matching to position for probing cognitive flexibility and working memory in mouse models of Huntington's disease.Quality of Life of Cypriot Patients Suffering with Huntington's Disease.Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin?Cognitive impairment in Huntington disease: diagnosis and treatment.Earliest functional declines in Huntington diseaseIdentification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease"Pre-symptomatic" Huntington's diseaseCognitive change in patients with Huntington disease on the Repeatable Battery for the Assessment of Neuropsychological Status.Randomized controlled trial of atomoxetine for cognitive dysfunction in early Huntington disease.Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study.Problem solving, impulse control and planning in patients with early- and late-stage Huntington's diseaseA review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases.Early Detection of Huntington Disease.Emerging drug therapies in Huntington's disease.A multidimensional approach to apathy after traumatic brain injury.Current therapeutic options for Huntington's disease: good clinical practice versus evidence-based approaches?A systematic review of the validity and reliability of apathy scales in neurodegenerative conditions.Striatal Neuropeptides Enhance Selection and Rejection of Sequential Actions.Exploring the Validity of the Short Version of the Problem Behaviours Assessment (PBA-s) for Huntington's disease: A Rasch Analysis.Participants at the Leiden Site of the REGISTRY Study: A Demographic Approach.Everyday Functioning in Huntington's Disease: A Laboratory-Based Study of Financial Management Capacity.Adverse childhood experiences of persons at risk for Huntington's disease or BRCA1/2 hereditary breast/ovarian cancer.
P2860
Q24621818-C72163C1-F565-4B60-960D-6E95B7C9EAACQ24626017-7889EC7C-FF2E-4D59-B0A8-B791AEDAA936Q30390965-3C48A1EA-D5F3-475B-A90C-2E6F8FAD9BF0Q30439699-51F3FB6B-2426-430E-9418-E7954B037069Q31139428-24C107ED-981B-482E-BF17-C39BBE8B0E5DQ33604313-66E5F5D9-9560-4469-B060-CDC00B036332Q33790224-3FC263FA-3CB5-4DF3-A73F-9A21BA53F59AQ33831793-361F8FA1-E520-441F-819F-89025BE0F96AQ33854599-33C977A9-9348-4CBC-9B5C-830B0E138442Q33929560-2827F655-3DDA-40F3-B621-76E3C577A908Q34020545-E74A7F47-191F-40E5-B566-547037AFA269Q34299924-7E25F4A1-84AE-4A69-A012-5F767D38BC60Q34322005-9DB91F44-B90E-404A-837B-39B71ABF710BQ34861585-EB0AF7AE-A414-404F-8580-3528E2AC331BQ35089933-577F8543-5F1C-4413-9B89-84F9F991CBC1Q35309355-9FD11947-2011-43FC-BE35-C945B1DA58DEQ35356604-3DF9959F-09AF-4442-9486-D13C8632AC53Q35615127-EDB270AD-777A-4C6D-9257-0880BCDD9E42Q35760068-8F1F7A47-B3DD-4670-B5DF-0CF7A7C34AE5Q36213063-E9A5C842-32B7-4098-B973-7FD227C6509EQ36336471-D212EE1F-A7B8-4409-B3FF-1DC54CD360DAQ36773397-086F89E4-9A55-44D6-9B31-A2C63B171E77Q36776679-02660B1E-34D3-4161-ACF4-8D72FE3C389BQ36813683-FF98AC54-1B85-44F4-9E15-393CABAB0C49Q37217988-CE655F73-CFCA-44B1-A723-F6CA2DCF51F9Q37250316-7F019ED4-687D-4D6B-8571-B86CE13BBF48Q37250382-37A05FD1-D005-49AB-B6D4-124DF63FE2E4Q37254698-86DF79C2-3C0F-422D-AF53-E84422356778Q37284640-3FCF1530-A381-4216-8FDC-DEB3931DA322Q37323166-B80B3D8E-F01A-4F50-B5CA-D2F8D7981D7CQ37386063-6A0760D0-C078-46CB-AB7A-3800ABD28F82Q37488273-91C7EC24-1EF4-48D2-B0A2-FDCC4BC98F24Q38127104-E4813F46-2E35-47EF-8097-CCBF385A4BB4Q38244078-22CA97EE-0D83-4EF0-BA1E-6FED72DFA75FQ38263761-7A53EDB8-F057-4C15-AB90-9FC3B67E6A1BQ38372362-49465167-ECB1-44E5-9317-C77BA526DC01Q40118236-A89A1B4C-D8A8-4E65-95CC-C2E85985FD96Q45294016-623AAFBD-0437-40FD-A723-E4FC71B5B77AQ45294436-A1D8C340-0562-4677-B28B-601F05C8BF57Q45304182-8F30512D-A432-456C-AA56-A647096D4A1F
P2860
Behavioural abnormalities contribute to functional decline in Huntington's disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Behavioural abnormalities contribute to functional decline in Huntington's disease.
@ast
Behavioural abnormalities contribute to functional decline in Huntington's disease.
@en
type
label
Behavioural abnormalities contribute to functional decline in Huntington's disease.
@ast
Behavioural abnormalities contribute to functional decline in Huntington's disease.
@en
prefLabel
Behavioural abnormalities contribute to functional decline in Huntington's disease.
@ast
Behavioural abnormalities contribute to functional decline in Huntington's disease.
@en
P2093
P356
P1476
Behavioural abnormalities contribute to functional decline in Huntington's disease
@en
P2093
D P Salmon
J Corey-Bloom
J M Hamilton
M W Jacobson
P304
P356
10.1136/JNNP.74.1.120
P407
P577
2003-01-01T00:00:00Z